Hélène Caillon

Years Active: 2019-2019
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Hélène Caillon, Pierre Peterlin, Patrice Chevallier, Thierry Guillaume, Amandine Lebourgeois, Alice Garnier, Martine Ropert-Bouchet, Thomas Dejoie
Eltrombopag induces major non-toxic hypersiderraemia. British journal of haematology 186 (2) (2019)
Eileen Mary Boyle, Xavier Leleu, Marie-Odile Petillon, Lionel Karlin, Chantal Doyen, Hélène Demarquette, Bruno Royer, Margaret Macro, Phillipe Moreau, Karel Fostier, Chretien Marie-Lorraine, Charles Zarnitsky, Aurore Perrot, Charles Herbaux, Stephanie Poulain, Salomon Manier, David Beauvais, Brian A Walker, Christopher P Wardell, Laure Vincent, Laurent Frenzel, Hélène Caillon, Schraen Susanna, Thomas Dejoie, Hervé Avet-Loiseau, Mohamad Mohty, Thierry Facon, null null
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial. British journal of haematology 187 (3) (2019)

Hélène Caillon.css-eqlu8i{font-size:small;padding-left:4px;}